Portal de Periódicos da CAPES

Neuraxial opioid-induced pruritus: a review

2003; Elsevier BV; Volume: 15; Issue: 3 Linguagem: Inglês

10.1016/s0952-8180(02)00501-9

1873-4529

Szilvia Szarvas, Dominic Harmon, Damian B. Murphy,

Asthma and respiratory diseases

When intrathecal and epidural opioids are administered, pruritus occurs as an unwanted and troublesome side effect. The reported incidence varies between 30% and 100%. The exact mechanisms of neuraxial opioid-induced pruritus remain unclear. Postulated mechanisms include the presence of an "itch center" in the central nervous system, medullary dorsal horn activation, and antagonism of inhibitory transmitters. The treatment of intrathecal opioid-induced pruritus remains a challenge. Many pharmacological therapies, including antihistamines, 5-HT3-receptor antagonists, opiate-antagonists, propofol, nonsteroid antiinflammatory drugs, and droperidol, have been studied. In this review, we will summarize pathophysiological and pharmacological advances that will improve understanding and ultimately the management of this troublesome problem.